In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion

Despite the poor prognosis associated with myelomeningocele (MMC), the options for prenatal treatments are still limited. Recently, fetal cellular therapy has become a new option for treating birth defects, although the therapeutic effects and mechanisms associated with such treatments remain unclea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Abe, Yushi, Ochiai, Daigo, Masuda, Hirotaka, Sato, Yu, Otani, Toshimitsu, Fukutake, Marie, Ikenoue, Satoru, Miyakoshi, Kei, Okano, Hideyuki, Tanaka, Mamoru
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Fetal and Neonatal Stem Cells
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811697/
https://ncbi.nlm.nih.gov/pubmed/31407874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars